Clinical Trials on Crush Syndrome
Total 0 results
Nothing found
Sponsors and Collaborators
- Daniela Pacella - University of Naples Federico II, Naples
- Ouctomes Research Consortium, Cleveland Clinic, Ohio, USA
- Etan Orgel
- The Australia-Israel Scientific Exchange Foundation (AISEF)
- Dr Philippe METELLUS
- ECMC
- AlpinARC
- the people hospital of Linzhi
- Sahachat Aueyingsak
- Direction Interarmées du Service de Santé des Armées (DIASS) de Cayenne, French Guiana
- ASSOCIATION POUR LE DEVELOPPEMENT EN FECONDATION IN VITRO
- Hospitales Universitarios Virgen del Rocío
- Sublimity Therapeutics Holdco Limited
- IRCCS Istituto Auxologico Italiano, Milano, Italy
- Åke Wibergs Stiftelse
- Centro Universitário Franciscano
- Bassam Abdulkarim
- Glasgow Western Infirmary
- National Institute of Cardiovascular Diseases, Bangladesh
- ADOR - Territorial Support Network, Device and Tools for Primary Care Teams
- View Full List
Medical Conditions
- Patients With Leptomeningeal Disease
- Eosinophil Blood Count
- Adult Patients Undergoing Surgery That Requires General Anesthesia
- Orthopaedic Disorders
- Value-Based Health Insurance
- Implanted With Any Currently (and Any Future) FDA-approved Medtronic ICD or CRT Device
- Failed Open Reduction Internal Fixation (ORIF) of a Radial Head Fracture
- Panniculectomy
- Progression to PD-1 Antibody
- Very Long Chain Acyl Coa Dehydrogenase Deficiency
- Ability to Swim 100m Independent Freestyle
- Pancreaticoduodenectomy
- Genetic Risk Factor
- Hyperprolinemia
- Interviews
- Transitional Cell Carcinoma of Renal Pelvis
- Degenerative Spondylolisthesis G1
- Initiation of Depo-Provera (DMPA)
- Legal History
- Bladder Cancer TNM Staging Primary Tumor (T) T2B
- View Full List
Drug Interventions
- 5-Fluoro-uracil
- Omeprazole 20mg
- Cefuroxime 750mg oral
- Metoclopramide + dexamethasone
- Gefitinib
- 0% N2O
- Paliperidone palmitate
- Nimotuzumab
- Erythropoietin
- Prasugrel
- ATG-008 30 mg, orally, QD, each 4 week (28-day) a cycle
- Injectable Insulin
- 6% hetastarch
- Mepivacaine
- Epirubicin hydrochloride
- Antibiotic treatment
- HBM4003 and Triprilimab
- ASP8062
- IV rtPA (intravenous recombinant plasminogen activator)
- UFUR and Iressa
- View Full List
CROs by country
- Contract Research Organizations in Albania
- Contract Research Organizations in Congo
- Contract Research Organizations in Djibouti
- Contract Research Organizations in Egypt
- Contract Research Organizations in Ireland
- Contract Research Organizations in Liberia
- Contract Research Organizations in Lithuania
- Contract Research Organizations in Luxembourg
- Contract Research Organizations in Macedonia
- Contract Research Organizations in Malawi
- Contract Research Organizations in Moldova
- Contract Research Organizations in Montenegro
- Contract Research Organizations in Paraguay
- CRO list by country